Tytuł pozycji:
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
-
Tytuł:
-
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
-
Autorzy:
-
Lu, C.
Terbuch, A.
Dolling, D.
Yu, J.
Wang, H.
Chen, Y.
Fountain, J.
Bertan, C.
Sharp, A.
Carreira, S.
Isaacs, W.B.
Antonarakis, E.S.
De Bono, J.S.
Luo, J.
-
Źródło:
-
In Annals of Oncology September 2020 31(9):1178-1185
-